Last reviewed · How we verify

insulin eye drops — Competitive Intelligence Brief

insulin eye drops (insulin eye drops) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical peptide therapeutic. Area: Ophthalmology.

marketed Topical peptide therapeutic Insulin receptor (IGF-1R cross-reactivity possible) Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

insulin eye drops (insulin eye drops) — Hotel Dieu de France Hospital. Insulin eye drops deliver insulin topically to the ocular surface to promote corneal epithelial healing and reduce inflammation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
insulin eye drops TARGET insulin eye drops Hotel Dieu de France Hospital marketed Topical peptide therapeutic Insulin receptor (IGF-1R cross-reactivity possible)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical peptide therapeutic class)

  1. Hotel Dieu de France Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). insulin eye drops — Competitive Intelligence Brief. https://druglandscape.com/ci/insulin-eye-drops. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: